title: Influence of inflammatory nociception on the anxiolytic-like effect of diazepam and buspirone in rats.
abstract: BACKGROUND
  The effect of anxiety on nociception has been evaluated but not that of nociception on anxiety.
  
  
  OBJECTIVE
  The study was conducted to analyse the influence of nociception on basal levels of anxiety-like behaviour and on the action of anxiolytic drugs.
  
  
  METHODS
  Nociception was induced by an intra-articular injection of uric acid at 3.75 or 7.5%. Experimental anxiety was determined in the rat burying behaviour and the elevated plus maze tests. To separate specific anxiety-related drug actions, a spontaneous ambulatory test was included. The anxiolytics, buspirone (2.5 and 5.0 mg/kg, i.p.) and diazepam (0.5, 1.0 and 2.0 mg/kg, i.p.), were used.
  
  
  RESULTS
  In the nociception test, the pain-induced functional impairment rat model, uric acid at 3.75 and 7.5% had an effect of around 35 and 75%, respectively. Uric acid (UA) at the lower dose (3.75%) lacked an effect on burying behaviour but significantly increased the time spent and number of entries to the open arms; the higher UA dose (7.5%) produced a significant increase in the time spent and number of entries to the open arms and a statistically significant reduction in cumulative burying. Diazepam and buspirone produced a clear dose-dependent reduction in cumulative burying. In the plus maze, diazepam also induced an increase in the time spent and number of entries to the open arms. In the burying behaviour test, rats with a mild level of nociception (uric acid at 7.5%) were insensitive to the anxiolytic-like effect of these anxiolytic drugs. In the plus maze test, the anxiolytic-like effect of diazepam (1.0 mg/kg) was blocked under both levels of nociception.
  
  
  CONCLUSIONS
  These data demonstrate that nociception modifies the response to anxiolytic drugs. The role of factors with anxiogenic properties produced during inflammation, which may modify diazepam and buspirone effects, is discussed.
authors.affiliation: Departamento de Farmacobiología, Centro de Investigación y Estudios Avanzados del IPN, Calz. de los Tenorios 235, Col. Granjas Coapa, Mexico, 14330, DF, Mexico. jfernand@mail.cinvestav.mx
authors.forename: A
authors.initials: A
authors.lastname: Fernández-Guasti
authors.forename: R
authors.initials: R
authors.lastname: Reyes
authors.forename: L
authors.initials: L
authors.lastname: Martínez-Mota
authors.forename: F J
authors.initials: FJ
authors.lastname: López-Muñoz
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy* / Q000503:physiopathology; D001241:Aspirin / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D002065:Buspirone / Q000008:administration & dosage / Q000627:therapeutic use*; D003975:Diazepam / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D007249:Inflammation / Q000139:chemically induced / Q000503:physiopathology; D007270:Injections, Intra-Articular; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D009043:Motor Activity / Q000187:drug effects; D010146:Pain / Q000139:chemically induced / Q000503:physiopathology*; D051381:Rats; D017208:Rats, Wistar; D014527:Uric Acid
chemical_list: D014151:Anti-Anxiety Agents; D014527:Uric Acid; D003975:Diazepam; D001241:Aspirin; D002065:Buspirone
references.citation: Eur J Pharmacol. 2003 Jan 24;460(2-3):99-107
references.pmid: 12559369
references.citation: Eur J Pharmacol. 2003 May 23;469(1-3):71-9
references.pmid: 12782187
references.citation: Psychoneuroendocrinology. 1992 Nov;17(6):681-9
references.pmid: 1287686
references.citation: J Affect Disord. 1998 Mar;48(2-3):149-55
references.pmid: 9543204
references.citation: Psychopharmacology (Berl). 1996 Sep;127(1):1-9
references.pmid: 8880937
references.citation: J Neuroimmunol. 2000 Nov 1;111(1-2):131-8
references.pmid: 11063830
references.citation: J Am Med Womens Assoc (1972). 2002 Spring;57(2):91-4
references.pmid: 11991428
references.citation: Immunopharmacol Immunotoxicol. 2001 May;23 (2):253-65
references.pmid: 11417852
references.citation: Pharmacol Biochem Behav. 2001 Sep;70(1):85-93
references.pmid: 11566145
references.citation: Neurosci Biobehav Rev. 1985 Summer;9(2):203-22
references.pmid: 2861589
references.citation: Psychopharmacology (Berl). 1989;99(3):374-80
references.pmid: 2574479
references.citation: Pain. 1988 Oct;35(1):105-13
references.pmid: 3200595
references.citation: J Neurosci Methods. 1985 Aug;14(3):149-67
references.pmid: 2864480
references.citation: Pharmacol Biochem Behav. 1996 May;54(1):299-303
references.pmid: 8728571
references.citation: J Pharm Pharmacol. 2002 Mar;54(3):405-12
references.pmid: 11902807
references.citation: Pharmacology. 2003 Aug;68(4):183-9
references.pmid: 12837972
references.citation: J Lipid Res. 2003 Oct;44(10):1984-91
references.pmid: 12837849
references.citation: Psychopharmacology (Berl). 1987;91(3):305-15
references.pmid: 3104952
references.citation: Psychopharmacology (Berl). 2000 Jun;150(3):300-10
references.pmid: 10923758
references.citation: Life Sci. 2003 Apr 11;72(21):2361-8
references.pmid: 12639701
references.citation: Psychosom Med. 2001 May-Jun;63(3):476-86
references.pmid: 11382276
references.citation: Pain. 1994 Jun;57(3):383-91
references.pmid: 7936716
references.citation: Pharmacol Biochem Behav. 1981 Oct;15(4):619-26
references.pmid: 6117086
references.citation: J Chronic Dis. 1975 Jan;28(1):51-62
references.pmid: 1110264
references.citation: Alcohol. 2000 Jul;21(3):287-90
references.pmid: 11091033
references.citation: J Gen Psychol. 1980 Jul;103(1st Half):131-8
references.pmid: 7411121
references.citation: Br J Biomed Sci. 2001;58(2):111-21
references.pmid: 11440203
references.citation: J Chronic Dis. 1965 Jan;18:99-106
references.pmid: 14252274
references.citation: Biol Psychiatry. 2000 May 15;47(10):910-20
references.pmid: 10807964
references.citation: Drugs. 1994 Jul;48(1):25-40
references.pmid: 7525193
references.citation: Pharmacol Biochem Behav. 1990 May;36(1):203-5
references.pmid: 1971951
references.citation: Brain Res. 1987 Oct 13;423(1-2):395-8
references.pmid: 3676817
references.citation: Psychopharmacology (Berl). 1990;102(4):507-13
references.pmid: 1965750
references.citation: Physiol Behav. 1999 Nov;67(5):651-7
references.pmid: 10604834
references.citation: Pain. 1983 Jun;16(2):109-10
references.pmid: 6877845
references.citation: Pharmacol Biochem Behav. 2003 May;75(2):473-9
references.pmid: 12873640
references.citation: Brain Res. 2004 Jan 16;996(1):31-40
references.pmid: 14670628
references.citation: Pharmacol Toxicol. 1991 Sep;69(3):149-56
references.pmid: 1796057